Prostatis Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$23.6M |
| 2 |
iShares US Consumer Staples ETF
IYK
|
+$22.8M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$10.7M |
| 4 |
Danaher
DHR
|
+$9.71M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$9.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Healthcare Providers ETF
IHF
|
+$8.63M |
| 2 |
ProShares Short S&P500
SH
|
+$6.76M |
| 3 |
Amgen
AMGN
|
+$999K |
| 4 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$926K |
| 5 |
Johnson & Johnson
JNJ
|
+$629K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.12% |
| 2 | Technology | 3.03% |
| 3 | Industrials | 2.47% |
| 4 | Consumer Staples | 1.65% |
| 5 | Financials | 1.63% |
Similar funds
Prostatis Group's Q2 2023 Portfolio in Review
As of Q2 2023, Prostatis Group held 253 positions worth $215M, up 13% from $189M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prostatis Group deployed $485M of net new capital in Q2 2023, opening 155 new positions and adding to 55 existing holdings. Its largest new stake was iShares US Consumer Staples ETF: 339,651 shares worth $9.66M.
By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, down from 86% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was ProShares Short S&P500, an estimated $6.76M trimmed.
- Prostatis Group's largest Q2 2023 buy was iShares US Consumer Staples ETF: 339,651 shares worth $9.66M.
- Prostatis Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $23.6M increase.
- Prostatis Group's biggest Q2 2023 reduction was ProShares Short S&P500, cutting an estimated $6.76M.
- Prostatis Group fully exited iShares US Healthcare Providers ETF in Q2 2023, selling an estimated $8.63M.
- Prostatis Group's ten largest holdings make up 45% of its $215M portfolio in Q2 2023.
- Prostatis Group opened 155 new positions and closed 3 in Q2 2023.
- Prostatis Group's portfolio value rose 13% quarter-over-quarter to $215M.
Based on Prostatis Group's 13F filing for Q2 2023, filed 14 Aug 2023.